Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma

BACKGROUND: Patients with advanced gallbladder and biliary tract carcinoma face a dismal prognosis, as no effective palliative chemotherapy exists. The antitumor effect of gemcitabine is schedule-dependent rather than dose-dependent. We evaluated the activity of a prolonged infusion of gemcitabine i...

Descripción completa

Detalles Bibliográficos
Autores principales: von Delius, Stefan, Lersch, Christian, Schulte-Frohlinde, Ewert, Mayr, Martina, Schmid, Roland M, Eckel, Florian
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1180427/
https://www.ncbi.nlm.nih.gov/pubmed/15949047
http://dx.doi.org/10.1186/1471-2407-5-61

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1180427/
https://www.ncbi.nlm.nih.gov/pubmed/15949047
http://dx.doi.org/10.1186/1471-2407-5-61

Ejemplares similares